A tetrapeptide bioregulator (Ala-Glu-Asp-Leu) targeting bronchial and respiratory tissue. Part of the Khavinson bioregulator family. Used for respiratory health support, bronchial conditions, and lung tissue regeneration.

Is Bronchogen FDA approved?

No, Bronchogen is not FDA approved. Current status: Preclinical research, approved in Russia as supplement

What are the side effects of Bronchogen?

Reported side effects of Bronchogen include: Generally well-tolerated, Limited safety data outside Russia, Not FDA approved.

What is the typical dosing for Bronchogen?

Doses from bioregulator supplement protocols. Common doses observed in research: 10-20 mg daily. Duration: 10-30 day cycles. Administration: Oral capsules or sublingual.

Bioregulators

Bronchogen

Also known as: Ala-Glu-Asp-Leu, AEDL

Preclinical

Popular For

Respiratory health, COPD, lung function, bronchitis

Key Facts: Bronchogen

Category: Bioregulators
FDA Status: Not FDA Approved
Clinical Status: Preclinical research, approved in Russia as supplement
Administration: Oral capsules or sublingual
Typical Dose: 10-20 mg daily
Frequency: Once or twice daily
Evidence Level: Preclinical
Duration: 10-30 day cycles

Also Known As

Ala-Glu-Asp-Leu, AEDL

Mechanism of Action

Bronchogen regulates gene expression in bronchial epithelial cells and lung tissue. Like other Khavinson bioregulators, it works through tissue-specific peptide signaling to normalize cellular function and promote tissue repair in the respiratory system. It may help restore bronchial mucosa and support pulmonary function.

Research Summary

Research from the St. Petersburg Institute of Bioregulation and Gerontology shows Bronchogen's effects on bronchial tissue normalization. Studies in elderly patients demonstrated improvements in respiratory function parameters. Part of the Khavinson peptide bioregulator series with documented effects on tissue-specific gene regulation.

Clinical Status:Preclinical research, approved in Russia as supplement

Trial Progress:Preclinical

Pre

III

FDA

Dosing Information

Preclinical·Animal and cell studies, limited human data

Note: Animal study doses may not translate directly to humans.

Typical DosingⓘDoses commonly used by people in practice, based on community reports and anecdotal experience.

Community experience

Common Dose

10-20 mg daily

Range

10-20 mg daily

Frequency

Once or twice daily

Respiratory/bronchial bioregulator from Khavinson research. Often used for COPD, bronchitis, asthma support, and general lung health. Run in cycles of 10-30 days. Can be combined with other bioregulators.

Research DosingⓘDoses from published scientific studies and clinical trials. May include human or animal research.

Scientific studies

Doses from bioregulator supplement protocols

Doses from Studies

10-20 mg daily

Duration

10-30 day cycles

Administration

Oral capsules or sublingual

Timing & Administration

Best Time to Take

Morning on empty stomach

Once or twice daily

Food Recommendation

Take on empty stomach

Why This Timing?

Peptide bioregulators typically taken fasted for optimal absorption

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

●Generally well-tolerated
●Limited safety data outside Russia
●Not FDA approved

References

https://www.khavinson-peptides.com/bronchogen

Related Peptides

Peptides commonly compared with Bronchogen or used in similar applications.

Chonluten

Preclinical

A tripeptide bioregulator targeting respiratory and lung tissue. Supports healthy lung function and stomach lining. Regulates inflammatory and proliferative processes in respiratory epithelium.

Bioregulators

Testagen

Preclinical

A peptide bioregulator targeting testicular tissue. Supports healthy testicular function through tissue-specific gene regulation. Part of the Khavinson peptide bioregulator family.

Bioregulators

Livagen

Preclinical

A tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed by Khavinson that modulates chromatin structure and gene expression. Research shows it can decondense heterochromatin and activate ribosomal genes, potentially restoring more youthful gene expression patterns in aging cells.

Bioregulators

Ovagen

Preclinical

A tripeptide bioregulator (Glu-Asp-Leu) targeting liver and gastrointestinal tissue. Derived from liver tissue extracts, Ovagen modulates gene expression related to detoxification, antioxidant defense, and hepatocellular repair.

Bioregulators

Cortagen

Preclinical

A tetrapeptide bioregulator (Ala-Glu-Asp-Pro) derived from cerebral cortex extracts. Studied for neuroprotection, neural differentiation, and cognitive support. Regulates neurotrophic signaling and synaptic stability.

Bioregulators

Vesugen

Preclinical

A tripeptide bioregulator (Lys-Glu-Asp) targeting vascular tissue. Promotes restoration of blood vessel tissues and normalization of vascular function. Stimulates endothelial cell proliferation markers.

Bioregulators

How to Use Bronchogen Bronchogen Alternatives Compare with Similar Browse All Peptides

Looking for a trusted vendor?

Pro members get access to verified vendors with quality standards & exclusive discount codes.

View Verified Vendors

PRO

Want updates on Bronchogen research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Educational Information Only

This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.

Back to all peptides